Chicken consumption predisposes to diabetes through epigenetic modification by miRNAs: an in-silico prediction
- Northern Railway Hospital, Associated Sri Mata Vaishno-Devi Narayana Superspeciality Hospital (SVDNSH), Katra, J&K 182320, India
- Department of Pharmaceutical Sciences, Faculty of Applied Sciences and Technology, University of Kashmir, Hazratbal, Srinagar-190006, J&K, India
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (Mohali), Punjab-160062, India
- Department of Pharmacognosy and Phytochemistry, SPER, Jamia Hamdard University, New Delhi, 110062, India
- Received
- Published
Abstract
Diabetes is among the most worldwide occurring metabolic disorders. It has created a substantial socioeconomic burden because of no targeted therapy available to date. Epigenetic modifications are playing a significant role in its cause and cure. The food we eat can lead to epigenetic changes, which further can alter the expression of different genes. In the current research, we postulate that meat consumers might have a high risk of diabetes due to miRNA's ability to instigate epigenetic modifications of genes involved in diabetes. We performed bioinformatics analysis in which first we retrieved chicken miRNAs data from miRbase. Then we checked the interaction with target genes IGF2BP2, HNF1B, and TCF7L2 of obtained miRNAs utilizing miRanda and TargetScan databases. The interaction score obtained indicated good interaction between them. Based on the predicted miRNA-mRNA interactions score, we drew a miRNA network using miRNet software. The results obtained from this in-silico analysis suggest that chicken consumption may predispose diabetes through miRNAs associated with epigenetic modifications of the gene involved in diabetes. The outcome of this study can be further explored in cell-based, animal-based, and human-based studies.
References
- Aune, D., Ursin, G., and Veierod, M.B. (2009). Meat consumption and the risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia 52: 2277–2287.
- Chen, X., Ayala, I., Shannon, C., Fourcaudot, M., Acharya, N.K., Jenkinson, C.P., et al. (2018). The diabetes gene and Wnt pathway effector TCF7L2 regulates adipocyte development and function. Diabetes 67: 554–568.
- Cho, S.B., Kim, S.C., and Chung, M.G. (2019). Identification of novel population clusters with different susceptibilities to type 2 diabetes and their impact on the prediction of diabetes. Sci. Rep. 9: 3329.
- Damcott, C.M., Pollin, T.I., Reinhart, L.J., Ott, S.H., Shen, H., Silver, K.D., et al. (2006). Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55: 2654–2659.
- Dubois-Laforgue, D., Cornu, E., Saint-Martin, C., Coste, J., Bellanné-Chantelot, C., and Timsit, J. (2017). Diabetes, associated clinical spectrum, long-term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Care 40: 1436–1443.
- Goda, N., Murase, H., Kasezawa, N., Goda, T., and Yamakawa-Kobayashi, K. (2015). Polymorphism in microRNA-binding site in HNF1B influences the susceptibility of type 2 diabetes mellitus: a population based case–control study. BMC Med. Genet. 16: 75.
- Gu, T., Horová, E., Möllsten, A., Seman, N.A., Falhammar, H., Prázný, M., et al. (2012). IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy. J. Diabetes Complications 26: 393–398.
- Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., and Shaw, J.E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103: 137–149.
- Hashimoto, N., and Tanaka, T. (2017). Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus. J. Hum. Genet. 62: 141–150.
- Kobberling, J. (1982). Empirical risk figures for first degree relatives of non-insulin dependent diabetes. Genet. Diabetes Mellit. 201:.
- Ortega, Á., Berná, G., Rojas, A., Martín, F., and Soria, B. (2017). Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate. Int. J. Mol. Sci. 18:.
- Pan, A., Sun, Q., Bernstein, A.M., Schulze, M.B., Manson, J.E., Willett, W.C., et al. (2011). Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am. J. Clin. Nutr. 94: 1088–1096.
- Poulsen, P., Grunnet, L.G., Pilgaard, K., Storgaard, H., Alibegovic, A., Sonne, M.P., et al. (2009). Increased risk of type 2 diabetes in elderly twins. Diabetes 58: 1350–1355.
- Poulsen, P., Kyvik, K.O., Vaag, A., and Beck-Nielsen, H. (1999). Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia 42: 139–145.
- Pradhan, P., Upadhyay, N., Tiwari, A., and Singh, L.P. (2016). Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression. New Front. Ophthalmol. 2: 192.
- Rana, S., Kumar, S., Rathore, N., Padwad, Y., and Bhushana, S. (2016). Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases. Curr. Genomics 17: 261–278.
- Rao, P., Wang, H., Fang, H., Gao, Q., Zhang, J., Song, M., et al. (2016). Association between IGF2BP2 polymorphisms and type 2 diabetes mellitus: a case–control study and meta-analysis. Int. J. Environ. Res. Public Health 13: 574.
- Tiwari, J., Gupta, G., Jesus Andreoli Pinto, T. de, Sharma, R., Pabreja, K., Matta, Y., et al. (2018). Role of microRNAs (miRNAs) in the pathophysiology of diabetes mellitus. Panminerva Med. 60: 25–28.
- Vang, A., Singh, P.N., Lee, J.W., Haddad, E.H., and Brinegar, C.H. (2008). Meats, processed meats, obesity, weight gain and occurrence of diabetes among adults: findings from Adventist Health Studies. Ann. Nutr. Metab. 52: 96–104.
- Villareal, D.T., Robertson, H., Bell, G.I., Patterson, B.W., Tran, H., Wice, B., et al. (2010). TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59: 479–485.
Downloads

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Ishfaq Ahmad Bhat, Aasiya Bashir, Lahanya Guha, Ahmar Khan, Farheen Azad
License terms
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.